• Cy5 Goat Anti-Mouse IgG (H+L) in Cell Assays

  2026-08-14

  Learn how Cy5 Goat Anti-Mouse IgG (H+L) Antibody, SKU K1210, supports reproducible immunofluorescence and flow-cytometry workflows alongside cell viability, proliferation, and cytotoxicity assays. Scenario-based guidance covers compatibility, optimization, interpretation, storage, and vendor selection.

• JNK-IN-7 and Infection-Driven Apoptosis

  2026-08-13

  JNK-IN-7 offers a mechanistically precise way to test whether JNK activity links fungal recognition to epithelial apoptosis. This translational perspective connects Candida krusei biology with selective kinase perturbation, assay design, and pathway-specific interpretation.

• Plk1 Control of p31comet in Checkpoint Disassembly

  2026-08-13

  The reference study identifies Polo-like kinase 1 (Plk1) as a direct regulator of p31comet, a factor that works with TRIP13 to disassemble mitotic checkpoint complexes. Its biochemical and mutational evidence supports a model in which Plk1 phosphorylation of p31comet at S102 restrains checkpoint disassembly during mitosis and limits futile cycling between checkpoint assembly and disassembly.

• Nile Red as a Translational Lipid Map

  2026-08-12

  Nile Red, also known as Nile blue oxazone, can move lipid research beyond endpoint staining by linking droplet phenotypes to autophagy, lysosomal function, and translational decision-making. This thought-leadership guide explains how to use dual-channel fluorescence, rigorous controls, and orthogonal assays to interpret lipid storage dynamics in preclinical research.

• Tomivosertib Inhibition in Acute Myeloid Leukemia

  2026-08-12

  Suarez and colleagues showed that selective MNK1/2 inhibition with Tomivosertib suppresses eIF4E Ser209 phosphorylation, AML cell viability, and leukemic progenitor colony formation. The study also identified synergistic activity with Venetoclax and used proteomics to investigate MNK-associated protein complexes, providing a framework for biomarker-guided combination research.

• Resazurin Cell Viability Kit in Bone Research

  2026-08-11

  The Resazurin Cell Viability Assay Kit provides fluorescence- or color-based quantification of viable cells through resazurin reduction to resorufin. Its sensitivity and non-toxic workflow can support cell-level studies of Wnt-driven bone biology, but it does not replace osteogenic, molecular, or microcomputed-tomography endpoints.

• p-Cresyl Sulfate and Aortic Valve Calcification

  2026-08-10

  The 2026 reference study identifies p-cresyl sulfate as a direct enhancer of calcification in aortic valvular interstitial cells and links this effect to HIF-1α activation, klotho loss, and impaired SIRT1-associated signaling. Its combined porcine cell and rat chronic kidney disease models suggest that klotho and SIRT1 activation may interrupt PCS-associated NF-κB/RUNX2 signaling, while also defining important limits for translation to human calcific aortic valve disease.

• Elobixibat Hydrate: From IBAT Biology to Translation

  2026-08-09

  Elobixibat hydrate offers translational researchers a gut-focused way to interrogate bile acid circulation, intestinal motility, and metabolic signaling. This article connects selective IBAT inhibition with practical study design, clinical relevance, and a receptor-mapping framework informed by rapakinin research—while clearly separating established evidence from forward-looking hypotheses.

• Fluorouracil: Workflows for Tumor Resistance

  2026-08-08

  Build reproducible 5-Fluorouracil assays around thymidylate synthase inhibition, DNA-replication stress, and resistance biology. This practical guide connects dose–response design with the SMYD2–microRNA–P-glycoprotein findings reported in renal cancer research.

• Gramine Workflow for Ferroptosis Research

  2026-08-07

  Gramine is a mechanism-forward tool for connecting TNBC growth inhibition with ferroptosis, MTDH regulation, and CUL3 activity. This practical workflow covers formulation, dose-response design, target-engagement assays, rescue experiments, and troubleshooting for reproducible cancer biology research.

• Deferoxamine Mesylate: Iron-Chelating Agent for Oxidative St

  2026-08-07

  Deferoxamine mesylate stands out as a precision iron-chelating agent, enabling advanced control of oxidative stress, ferroptosis, and hypoxia signaling in cutting-edge laboratory models. This article delivers actionable workflows, troubleshooting insights, and evidence-driven strategies to maximize the impact of Deferoxamine mesylate in oncology, tissue regeneration, and metabolic research.

• Chemoproteomic SLC15A4 Inhibitors: Mechanisms and Anti-Infla

  2026-08-06

  This study introduces first-in-class, selective inhibitors of the endolysosomal transporter SLC15A4, establishing its role as a druggable target for autoimmune and autoinflammatory diseases. The chemoproteomic approach reveals how these inhibitors modulate critical immune signaling pathways, providing a foundation for targeted therapies with reduced off-target immune suppression.

• DAPI Solution (1 mg/mL): Precision Nuclear Visualization & A

  2026-08-06

  DAPI Solution (1 mg/mL) from APExBIO empowers high-fidelity nuclear visualization and apoptosis detection in both fixed and apoptotic cells, setting a benchmark for workflow optimization in cancer and immunology research. Unique protocol flexibility, robust compatibility with flow cytometry, and proven stability make it a trusted tool for advanced DNA quantification and viability assessment.

• V5 Epitope Tag Peptide: Optimizing Protein Detection Workflo

  2026-08-05

  The V5 Epitope Tag Peptide (GKPIPNPLLGLDST) delivers unmatched sensitivity and reproducibility for protein tagging, detection, and purification in molecular biology. Leveraging high-purity, robust solubility, and compatibility with advanced immunodetection strategies, this tag enables researchers to streamline workflows, troubleshoot challenging assays, and push the boundaries of multiplexed protein analysis.

• UHRF1-Driven DNA Methylation Alters Osteogenesis via TGM2-Au

  2026-08-05

  This study uncovers how UHRF1-mediated DNA 5-methylcytosine modification reshapes super-enhancer architecture and impairs osteogenic differentiation in senile osteoporosis. By connecting epigenetic DNA methylation dynamics to autophagic regulation via TGM2, the findings highlight new mechanistic targets for bone loss intervention.

451 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page